Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

Piper Sandler analyst Jason Bednar assigned a Buy rating to Beyond Air (XAIR – Research Report) today and set a price target of $1.00.

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Looking ahead, revenue ...

Penumbra and Inspire Medical Systems, providing valuable insights into their respective standings within the industry and their market positions and comparative performance. Masimo ranks at the ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...

The medical technology company posted adjusted ... slightly above the $502.87 million estimate and up 11.5% YoY. However, Masimo's fourth-quarter revenue guidance of $581-611 million fell below ...

Apple had been hoping to secure an injunction on the sale of Masimo's medical devices in the US. As it turned out, Masimo beat all but three of the patent infringement claims brought by Apple at ...

Irvine-based Masimo’s W1 Medical Watch gives “medical-grade accuracy a cut above most fitness trackers,” the magazine said.